Demetrios Georgiou MD in New York, New York

Home New York New York

Demetrios Georgiou MD has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 550 1st Ave in New York, New York. There is an additional office location, for a total of two, for Demetrios Georgiou MD that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-7300 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1979 (around 45 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Demetrios Georgiou MD Office Phone and Directions

Demetrios Georgiou MD
New York University
550 1st Ave
New York, New York 10016
212-263-7300

Patient Ratings
Please rate your experience with Demetrios Georgiou MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-7300

Enter a starting address:

Healthcare Info for Demetrios Georgiou MD

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Demetrios Georgiou MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 2466490396
NPI #: 1083661987
NPI Created On: 05/27/2006
NPI Last Updated Listed as: 09/18/2023
Primary Taxonomy Code: 207RC0000X
License Number:
166154
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Routine ekg using at least 12 leads including interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Doppler ultrasound study of heart blood flow, valves, and chambers
Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Physician telephone patient service, 11-20 minutes of medical discussion
Technetium tc-99m sestamibi, diagnostic, per study dose
Injection, aminophyllin, up to 250 mg
Injection, regadenoson, 0.1 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Educational Program

Record ID:: 829795777

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30